Treatment of upper limb deep vein thrombosis with low molecular weight heparin

被引:2
作者
Shah, MK [1 ]
Black-Schaffer, RM [1 ]
机构
[1] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA
关键词
upper extremity; deep vein thrombosis; treatment; low molecular weight heparin;
D O I
10.1097/01.PHM.0000064740.19570.2A
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Upper limb deep vein thrombosis has been an under-recognized disease; however, physicians' awareness of it as a cause of arm pain and edema is increasing. Previously thought of as benign, upper limb deep vein thrombosis has been shown in recent studies to pose a significant risk for pulmonary embolus and death. The need for treatment is now recognized; however, effective treatments for upper limb deep vein thrombosis have not been fully defined. Anticoagulation with oral agents is known to be successful in preventing complications and recurrence. This report presents the first case of upper limb deep vein thrombosis successfully treated with only low molecular weight heparin.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [41] Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
    Han, Ji Min
    Koh, Youngil
    Kim, Sung Hwan
    Suh, Sung Yun
    Cho, Yoon Sook
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Gwak, Hye Sun
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [42] Can all patients with deep vein thrombosis receive low-molecular-weight heparin in an outpatient setting?
    Lindmarker, P
    HAEMOSTASIS, 1999, 29 : 84 - 88
  • [43] Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients
    Levine, M
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 : 9 - 11
  • [44] The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients
    Lee, Tim H.
    Alonzo, Brock J.
    Differding, Jerome
    Underwood, Samantha J.
    Hamilton, Greg
    Kremenevskiy, Igor
    McNamara, Steve
    Schreiber, Martin A.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2013, 74 (02) : 476 - 481
  • [45] Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin
    Smith, BJ
    Weekley, JS
    Pilotto, L
    Howe, T
    Beven, R
    INTERNAL MEDICINE JOURNAL, 2002, 32 (1-2) : 29 - 34
  • [46] Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery
    Breddin, HK
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 83 - 89
  • [47] RANDOMIZED CONTROLLED-STUDY OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN FOR PREVENTION OF DEEP-VEIN THROMBOSIS IN MEDICAL PATIENTS
    HARENBERG, J
    KALLENBACH, B
    MARTIN, U
    DEMPFLE, CE
    ZIMMERMANN, R
    KUBLER, W
    HEENE, DL
    THROMBOSIS RESEARCH, 1990, 59 (03) : 639 - 650
  • [48] Foot Pump Versus Low-Molecular-Weight Heparin for Preventing Deep Vein Thrombosis Following Surgery for Hip and Knee Replacement
    Lin, Feng-Fei
    Chen, Bin
    Lin, Chao-Hui
    Zheng, Ke
    INTERNATIONAL SURGERY, 2021, 105 (1-3) : 389 - 396
  • [49] REGRESSION OF DEEP-VEIN THROMBOSIS BY IV-ADMINISTRATION OF A LOW-MOLECULAR-WEIGHT HEPARIN - RESULTS OF A PILOT-STUDY
    KIRCHMAIER, CM
    LINDHOFFLAST, E
    RUBESAM, D
    SCHARRER, I
    VIGH, Z
    MOSCH, G
    WOLF, H
    BREDDIN, HK
    THROMBOSIS RESEARCH, 1994, 73 (05) : 337 - 348
  • [50] Effect of low molecular weight heparin versus warfarin sodium on mortality in long-term treatment of proximal vein thrombosis
    Hull, RD
    Pineo, GF
    Brant, RF
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 : S4 - S11